BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bharathan VK, Chandran B, Gopalakrishnan U, Varghese CT, Menon RN, Balakrishnan D, Sudheer OV, Dhar P, Surendran S. Perioperative prostaglandin e1 infusion in living donor liver transplantation: A double-blind, placebo-controlled randomized trial. Liver Transpl 2016;22:1067-74. [PMID: 27152759 DOI: 10.1002/lt.24479] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Nickkholgh A, Maluf D. Emerging graft protective strategies in clinical liver transplantation. Expert Review of Gastroenterology & Hepatology 2017;11:623-31. [DOI: 10.1080/17474124.2017.1322901] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
2 Shajahan S, Sasidharan ST, Surendran S, Shenoy V, Padma UD. Lessons learnt from living donor liver transplantation with ABO-incompatibility: A single-centre experience from southern India. Indian J Gastroenterol 2019;38:23-8. [PMID: 30848450 DOI: 10.1007/s12664-019-00933-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
3 Zito G, Miceli V, Carcione C, Busà R, Bulati M, Gallo A, Iannolo G, Pagano D, Conaldi PG. Human Amnion-Derived Mesenchymal Stromal/Stem Cells Pre-Conditioning Inhibits Inflammation and Apoptosis of Immune and Parenchymal Cells in an In Vitro Model of Liver Ischemia/Reperfusion. Cells 2022;11:709. [DOI: 10.3390/cells11040709] [Reference Citation Analysis]
4 Shaji Mathew J, Kumar KYS, Nair K, Thankamony Amma BSP, Krishnakumar L, Balakrishnan D, Gopalakrishnan U, Menon RN, Sunny A, Dhar P, Othiyil Vayoth S, Surendran S. Antegrade Hepatic Artery and Portal Vein Perfusion Versus Portal Vein Perfusion Alone in Living Donor Liver Transplantation: A Randomized Trial. Liver Transpl 2019;25:1353-62. [PMID: 30908879 DOI: 10.1002/lt.25455] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Balakrishnan S, Kumar L, Daniel D, Surendran S. Anaesthetic implications and transfusion practices in ABO incompatible living donor liver transplantation: Case series. Indian J Anaesth 2021;65:331-5. [PMID: 34103749 DOI: 10.4103/ija.IJA_1295_20] [Reference Citation Analysis]
6 Zhang L, Li N, Cui LL, Xue FS, Zhu ZJ. Intraoperative Low-Dose Dexmedetomidine Administration Associated with Reduced Hepatic Ischemia-Reperfusion Injury in Pediatric Deceased Liver Transplantation: A Retrospective Cohort Study. Ann Transplant 2021;26:e933354. [PMID: 34650026 DOI: 10.12659/AOT.933354] [Reference Citation Analysis]
7 Medina S, De Las Heras-Gómez I, Casas-Pina T, Bultel-Poncé V, Galano JM, Durand T, Martínez-Hernández P, Ferreres F, Jimeno L, Llorente S, Gil-Izquierdo Á. Urinary oxylipin signature as biomarkers to monitor the allograft function during the first six months post-renal transplantation. Free Radic Biol Med 2020;146:340-9. [PMID: 31734358 DOI: 10.1016/j.freeradbiomed.2019.11.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Ono Y, Ono N, Shinohara K. Tissue Hypoperfusion, Hypercoagulopathy, and Kidney and Liver Dysfunction after Ingestion of a Naphazoline-Containing Antiseptic. Case Rep Emerg Med 2017;2017:3968045. [PMID: 28555165 DOI: 10.1155/2017/3968045] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Agopian VG, Harlander-Locke MP, Markovic D, Dumronggittigule W, Xia V, Kaldas FM, Zarrinpar A, Yersiz H, Farmer DG, Hiatt JR, Busuttil RW. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model. JAMA Surg 2018;153:436-44. [PMID: 29261831 DOI: 10.1001/jamasurg.2017.5040] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 12.7] [Reference Citation Analysis]
10 Dar WA, Sullivan E, Bynon JS, Eltzschig H, Ju C. Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms. Liver Int. 2019;39:788-801. [PMID: 30843314 DOI: 10.1111/liv.14091] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 22.0] [Reference Citation Analysis]
11 Xu J, Xia Y, Li S, Cheng X, Hu S, Gao Y, Zhou X, Wang G, Zheng Q. A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of postoperative acute kidney injury in patients with hepatocellular carcinoma. Ann Clin Biochem 2019;56:357-66. [PMID: 30453754 DOI: 10.1177/0004563218817797] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]